Therapeutic Options for Crigler-Najjar Syndrome: A Scoping Review.
Crigler–Najjar syndrome
UGT1A1 mutation
gene therapy
hyperbilirubinemia
liver transplantation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
13 Oct 2024
13 Oct 2024
Historique:
received:
13
09
2024
revised:
01
10
2024
accepted:
11
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
Crigler-Najjar Syndrome (CNS) is a rare genetic disorder caused by mutations in the
Identifiants
pubmed: 39456788
pii: ijms252011006
doi: 10.3390/ijms252011006
pii:
doi:
Substances chimiques
Glucuronosyltransferase
EC 2.4.1.17
UGT1A1 enzyme
EC 2.4.1.-
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM